DANIEL VON HOFF, M.D., F.A.C.P. FASCO, FAACR
Clinical Advisor

Daniel Von Hoff is Physician in Chief, Distinguished Professor at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona. Dr. Von Hoff has conducted more than 500 clinical trials to date and his clinical trial work has led to the approval of 3 of the 4 drugs approved by the FDA for treatment of patients with advanced pancreatic cancer, including gemcitabine and AbraxaneR combination therapy.